You are here

Healthcare Economics

 

Prescribing fixed-dose combination pills to patients with hypertension may help improve their adherence and persistence to their medications and encourage them to refill their prescription, according to a claims database analysis.

The American Heart Association (AHA) released a policy statement urging the Centers for Medicare & Medicaid Services (CMS) to cover evidence-based telehealth interventions for all Medicare beneficiaries who suffer from cardiovascular disease and stroke.

Performance-based risk-sharing deals allow payers to hedge their bets with new drugs while helping pharmaceutical companies grow market share.

If the Centers for Medicare & Medicaid Services (CMS) weighted 30-day readmissions and mortality equally, financial penalties in 2014 for U.S. hospitals would have substantially changed, according to an analysis of publicly available hospital data.

 

Recent Headlines

Readmissions for acute MI, heart failure are expensive, lead to long hospital stays

Readmissions for non-Medicare patients and in other settings are not as closely monitored, although a database analysis suggests that patients spend nearly a week in the hospital and cost nearly $10,000 per readmission.

Fixed-dose combination pills may improve adherence, persistence in adults with hypertension

Prescribing fixed-dose combination pills to patients with hypertension may help improve their adherence and persistence to their medications and encourage them to refill their prescription, according to a claims database analysis.

ACC submits comments to CMS on final MACRA rule

The American College of Cardiology (ACC) recently submitted comments to CMS regarding the final Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) rules that were released last fall.

Black, Hispanic adults may have poorer hypertension control than white patients

Black and Hispanic patients with hypertension had poorer control of their condition compared with white patients with hypertension, according to a cross-sectional study. The researchers found the differences in hypertension were more pronounced in younger and uninsured patients.

Tobacco's price tag? $1 trillion a year in healthcare costs

Tobacco products cost the world’s economies more than $1 trillion annually in healthcare expenditures and lost productivity, according to a new report from the World Health Organization (WHO) and the National Cancer Institute (NCI).

FDA says St. Jude Medical’s devices could face cybersecurity vulnerabilities

After reviewing information, the FDA announced on Jan. 9 that St. Jude Medical’s radio frequency (RF)-enabled implantable cardiac devices and the company’s Merlin@home transmitter could be subject to cybersecurity vulnerabilities.

Stroke diagnostics, therapeutics market to reach $31 billion by 2021

A study from Zion Research found that the stroke diagnosis and therapeutics markets has undergone accelerated growth in recent years due to the large patient pool in conjunction with an aging population across the globe. 

New CMS payment models affect cardiologists, hospitals throughout U.S.

Starting this year, a large number of cardiologists treating fee-for-service Medicare patients will participate in programs in which their reimbursement is tied to providing value-based care. It is the continuation of a trend that many leaders in the healthcare industry believe will become the norm.

Novartis reaches option agreement to license two investigational cardiovascular drugs

Novartis announced on Jan. 6 that it had reached an option agreement with two small pharmaceutical companies to license two investigational cardiovascular medications.

Judge rules Sanofi, Regeneron cannot sell PCSK9 inhibitor in the U.S.

A federal judge in Delaware ruled Jan. 5 that Sanofi and Regeneron Pharmaceuticals could not market or sell their proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor in the U.S.

Pages